Search Results - "Modest DP"

Neoadjuvant Radiochemotherapy and Total Neoadjuvant Therapy in the Management of Locally Advanced Rectal Cancer.

Authors: Yigit M Roohani S Kurreck A et al.

Source: Cureus [Cureus] 2025 Nov 10; Vol. 17 (11), pp. e96517. Date of Electronic Publication: 2025 Nov 10 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE

Proteomic profiling of colorectal liver metastases reveals histopathological response-specific molecular signatures of chemotherapy efficacy.

Authors: Böhm AK Skrip LM Klein O et al.

Source: Journal of translational medicine [J Transl Med] 2026 Mar 05; Vol. 24 (1). Date of Electronic Publication: 2026 Mar 05.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

Acute ischemic stroke, active malignancy and non-bacterial thrombotic endocarditis: an exploratory prospective observational study.

Authors: Frydas A Akay EM Ran H et al.

Source: Scientific reports [Sci Rep] 2026 Jul 15; Vol. 16 (1). Date of Electronic Publication: 2026 Jul 15.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 - PRODIGE 107 - FFCD 2306 - COLOSOTO trial.

Authors: Grancher A Landi M Ballhausen A et al.

Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2026 Jul; Vol. 58 (7), pp. 966-972. Date of Electronic Publication: 2026 May 01.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3562 (Electronic) Linking ISSN: 15908658 NLM ISO Abbreviation: Dig Liver Dis Subsets: MEDLINE

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF^V600E-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group).

Authors: Weiss L Stintzing S Modest DP et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jan; Vol. 232, pp. 116105. Date of Electronic Publication: 2025 Nov 13.

Publication Type: Comparative Study; Journal Article; Meta-Analysis; Comparative Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.

Authors: Heinrich K Stintzing S Weikersthal LFV et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jan; Vol. 232, pp. 116133. Date of Electronic Publication: 2025 Nov 22.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

PROTECTOR / FIRE‑10: study protocol for a prospective, randomized, open-label, multicenter phase III trial to investigate the efficacy of preoperative systemic therapy in advanced colon cancer.

Authors: Siegel R Dittrich L Plewe J et al.

Source: BMC cancer [BMC Cancer] 2026 Mar 20; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 20.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Requirements for a successful implementation of liver transplantation as a treatment option for non-resectable colorectal liver metastases into clinical routine - a narrative review.

Authors: Walter KA Moosburner S Kreutz T et al.

Source: Langenbeck's archives of surgery [Langenbecks Arch Surg] 2026 Mar 20; Vol. 411 (1). Date of Electronic Publication: 2026 Mar 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 9808285 Publication Model: Electronic Cited Medium: Internet ISSN: 1435-2451 (Electronic) Linking ISSN: 14352443 NLM ISO Abbreviation: Langenbecks Arch Surg Subsets: MEDLINE

Cancer evolution and multi-omic profile of relapsed colorectal liver metastases after treatment.

Authors: Tomás L Raschzok N Blanc E et al.

Source: Genome medicine [Genome Med] 2026 Feb 24; Vol. 18 (1). Date of Electronic Publication: 2026 Feb 24.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE

Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy.

Authors: Steup, Christoph Mondorf, Antonia Wild, Peter et al.

Source: PLoS ONE. 7/6/2026, Vol. 21 Issue 7, p1-17. 17p.

This result is not displayed to guests.
Login for full access.

Gender-based variations in surgical management of colorectal liver metastases: comprehensive analysis.

Authors: Koch PF Ludwig K Hillebrandt KH et al.

Source: BMC cancer [BMC Cancer] 2025 Feb 21; Vol. 25 (1), pp. 315. Date of Electronic Publication: 2025 Feb 21.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer.

Authors: Weiss L Stintzing S Stahler A et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 May 15; Vol. 221, pp. 115399. Date of Electronic Publication: 2025 Apr 04.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306.

Authors: Holch JW Ohnmacht AJ Stintzing S et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 May 02; Vol. 220, pp. 115388. Date of Electronic Publication: 2025 Mar 25.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances.

Authors: Chen Y Zhang J Ding Y et al.

Source: Molecular biomedicine [Mol Biomed] 2026 Mar 14; Vol. 7 (1). Date of Electronic Publication: 2026 Mar 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

Defining Standard Data Reporting in Pelvic Exenteration Surgery for Rectal Cancer: A PelvEx Collaborative Review of Current Data Reporting.

Source: Cancers. Sep2025, Vol. 17 Issue 17, p2764. 20p.

Prevalence and distribution of human papillomavirus in genital warts in Can Tho City, Vietnam: a cross-sectional study.

Authors: Ngan, Lac Thi Kim Ba, Huynh Van Kim, Dao Hoang Thien et al.

Source: Infectious Agents & Cancer. 8/18/2025, Vol. 20 Issue 1, p1-7. 7p.

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

Authors: Wang, De-Shen Ren, Chao Li, Shan-Shan et al.

Source: PLoS Medicine. 5/10/2024, Vol. 21 Issue 5, p1-18. 18p.

Clinical prognosticators and targets in the immune microenvironment of intrahepatic cholangiocarcinoma.

Authors: Lozzi I Arnold A Barone M et al.

Source: Oncoimmunology [Oncoimmunology] 2024 Oct 01; Vol. 13 (1), pp. 2406052. Date of Electronic Publication: 2024 Oct 01 (Print Publication: 2024).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial.

Authors: Taieb J Modest DP Fakih M et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Sep 09; Vol. 227, pp. 115644. Date of Electronic Publication: 2025 Jul 12.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE